In the wake of the diabetes pandemic, prevalence of non-alcoholic fatty liver disease (NAFLD) is on the rise. This course sets out the health implications and potential treatments for this serious but reversible condition.
Therapeutic inertia has been implicated as a significant contributory factor in suboptimal diabetes management. This course uses a Q&A format to explore the phenomenon, with particular focus on primary care.
From obscure origins in studies of lizard saliva, GLP-1 receptor agonists (GLP-1RAs) have become a staple of type 2 diabetes treatment. This course examines the ways in which they can aid type 2 diabetes management.
Hajj, the world’s oldest and largest mass gathering, is one of the Five Pillars of Islam. This course considers it in a clinical context, examining how people with diabetes can be supported to perform the rites safely.
Transplants of insulin-producing islets offer the hope of glucose regulation without daily insulin injections. This course looks at advances in this exciting field of diabetes treatment and the challenges still to come.
Over time, hyperglycaemia can result in damage to the nerves, with severe consequences for health – not just in the feet but all over the body. This course looks at diabetic neuropathy in all its forms.
The value attached to real-world evidence (RWE) in clinical decision making has significantly increased in recent years. Using examples taken from diabetes treatment, this course looks at what RWE is, why it is important and who can benefit from it.